BRIEF published on 01/21/2025 at 21:05, 1 year 5 months ago Fundraising of €0.25 million by Néovacs Fundraising Shareholder Dilution Néovacs OCEANE-BSA Kinoid® Research
BRIEF published on 01/21/2025 at 21:05, 1 year 5 months ago Levée de fonds de 0,25 M€ par Néovacs Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire Recherche Kinoïde®
PRESS RELEASE published on 01/21/2025 at 21:00, 1 year 5 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et les investissements en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 01/15/2025 at 20:05, 1 year 5 months ago Adjustment of the nominal value at Neovacs Investment Capital Reduction Nominal Value Néovacs Stock Market Shares
BRIEF published on 01/15/2025 at 20:05, 1 year 5 months ago Ajustement de la valeur nominale chez Néovacs Investissement Valeur Nominale Néovacs Actions Boursières Réduction Capital
PRESS RELEASE published on 01/15/2025 at 20:00, 1 year 5 months ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 1 euro à 0,50 euro, suite à une réduction de capital motivée par des pertes. La société française développe des thérapies pour maladies inflammatoires Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 12/18/2024 at 08:35, 1 year 6 months ago Levée de fonds par Néovacs Biotechnologie Levée De Fonds Dilution Néovacs OCEANE-BSA
BRIEF published on 12/18/2024 at 08:35, 1 year 6 months ago Fundraising by Neovacs Biotechnology Fundraising Dilution Néovacs OCEANE-BSA
PRESS RELEASE published on 12/18/2024 at 08:30, 1 year 6 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
BRIEF published on 09/18/2024 at 20:05, 1 year 9 months ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
Published on 07/03/2026 at 23:00, 1 day 10 hours ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 1 day 12 hours ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day 14 hours ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 20 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 17:35, 15 hours 55 minutes ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 22 hours 29 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 1 day 14 hours ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 1 day 14 hours ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 21:49, 1 day 11 hours ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 1 day 11 hours ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 14 hours ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 1 day 14 hours ago Disclosure of transactions in own shares from July 1 to July 3, 2026
